TP53 and neoplasm: Decreased phosphorylation of Akt, expression of Ki67, and HK2;Downregulation of aerobic glycolysis;Induction of the intrinsic apoptosis pathway;Reduced tumor volume and weight;Activation of the DNA damage response;Inhibition of cyclins and CDKs;Activation of p53 and p21.